Immunological conjugates of ompc and hiv-specific selected...

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/64 (2006.01) A61K 39/095 (2006.01) A61K 39/21 (2006.01) A61K 39/295 (2006.01) A61K 39/385 (2006.01) C07K 7/08 (2006.01) C07K 14/155 (2006.01) C07K 14/16 (2006.01) C07K 14/22 (2006.01) C07K 16/10 (2006.01) C07K 17/06 (2006.01) C12N 7/04 (2006.01) G01N 33/569 (2006.01) A61K 38/00 (2006.01) A61K 39/00 (2006.01)

Patent

CA 2139517

Immunological conjugates of HIV-specific selected principal neutralization epitopes are prepared. These epitopes bind a broadly neutralizing human monoclonal antibody specific for the HIV principal neutralization epitope(s) and are identified from oligopeptide epitope libraries. The conjugates are useful for vaccination against AIDS or ARC, as well as in the production of other HIV-specific broadly neutralizing antibodies for passive immunity against AIDS or ARC.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Immunological conjugates of ompc and hiv-specific selected... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immunological conjugates of ompc and hiv-specific selected..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunological conjugates of ompc and hiv-specific selected... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2047898

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.